...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma
【24h】

Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma

机译:在过敏性哮喘发病机制中偏见的一代和原位激活肺组织 - 植物记忆CD4 T细胞

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Asthma is a chronic inflammatory disease mediated by allergen-specific CD4 T cells that promote lung inflammation through recruitment of cellular effectors into the lung. A subset of lung T cells can persist as tissue-resident memory T cells (TRMs) following infection and allergen induction, although the generation and role of TRM in asthma persistence and pathogenesis remain unclear. In this study, we used a mouse model of chronic exposure to intranasal house dust mite ( HDM) extract to dissect how lung TRMs are generated and function in the persistence and pathogenesis of allergic airway disease. We demonstrate that both CD4 + and CD8 + T cells infiltrate into the lung tissue during acute HDM exposure; however, only CD4(+) TRMs, and not CD8 + TRMs, persist long term following cessation of HDM administration. Lung CD4(+) TRMs are localized around airways and are rapidly reactivated upon allergen re-exposure accompanied by the rapid induction of airway hyperresponsiveness independent of circulating T cells. Lung CD4(+) TRM activation to HDM challenge is also accompanied by increased recruitment and activation of dendritic cells in the lungs. Our results indicate that lung CD4(+) TRMs can perpetuate allergen-specific sensitization and direct early inflammatory signals that promote rapid lung pathology, suggesting that targeting lung CD4(+) TRMs could have therapeutic benefit in alleviating recurrent asthma episodes.
机译:哮喘是由过敏原特异性CD4 T细胞介导的慢性炎症性疾病,通过募集细胞效应促进肺部肺部肿瘤。在感染和过敏原后,肺T细胞的子集可以持续作为组织常存存储器T细胞(TRMS),尽管TRM在哮喘持续和发病机制中的产生和作用仍然尚不清楚。在这项研究中,我们使用了慢性暴露于鼻内尘埃粉尘(HDM)提取物的小鼠模型,以疏忽如何产生肺部,并且在过敏气道疾病的持续和发病机制中起作用。我们证明CD4 +和CD8 + T细胞在急性HDM暴露过程中渗透到肺组织中;但是,只有CD4(+)TM,而不是CD8 + TMS,在停止HDM管理后持续长期。肺CD4(+)TRMS围绕空道道局部化,并在过敏原重新曝光时迅速重新激活,伴随着循环T细胞的气道高反应性快速诱导。肺CD4(+)TRM激活对HDM挑战的激活还伴随着肺中树突细胞的募集和激活增加。我们的结果表明,肺CD4(+)TRMS可以延续过敏原特异性敏化和直接早期炎症信号,促进肺部病理学,这表明靶向肺CD4(+)TMS可能在减轻复发性哮喘发作方面具有治疗性益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号